Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision tag updated from v3.5.2 to v3.5.3, indicating a newer version of the page content; this is a versioning update rather than a substantive change to the study details.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision history updated: added v3.5.2 with entries for 2026-04-09 and 2026-04-13, and removed entries for v3.5.0 dated 2026-04-07 and 2026-04-08.SummaryDifference0.1%

- Check39 days agoChange Detected- The study page history shows additions of 2026-04-07 and 2026-04-08 and deletions of 2026-03-31 and 2026-04-01, reflecting update history.SummaryDifference0.0%

- Check46 days agoChange DetectedTwo dates (2026-04-01 and 2026-03-31) were added and two dates (2026-03-24 and 2026-03-21) were removed from the Study Record Dates.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision log updated to v3.5.0 with new timestamps (2026-03-21 and 2026-03-24), replacing the previous v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedStudy record dates show additions on 2026-03-14 and 2026-03-17, and deletions on 2026-03-07 and 2026-03-10.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.